市場調查報告書
商品編碼
1470407
空間組學市場:按技術、樣本類型、產品、工作流程和最終用途 - 2024-2030 年全球預測Spatial OMICS Market by Technology (Genomics, Proteomics, Transcriptomics), Sample Type (FFPE, Fresh Frozen), Product, Workflow, End-use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年空間組學市場規模為5.2118億美元,預計2024年將達5.8666億美元,2030年將達到12.3748億美元,複合年成長率為13.14%。
空間組學包含用於分析細胞、組織和生物體內生物分子空間組織的先進技術和技術。該部門服務於製藥、生物技術、學術研究和診斷等各行業。癌症等複雜疾病的盛行率不斷上升、次世代定序(NGS) 的進步以及政府對生命科學研究舉措的資助等因素正在擴大空間組學的應用領域。然而,與實施先進成像工具相關的高成本,以及資料標準化和互通性問題,可能會阻礙市場成長。然而,人工智慧 (AI) 和機器學習 (ML) 等蓬勃發展的技術有可能徹底改變空間組學研究中的資料分析。此外,利用雲端運算技術並整合轉錄組學、蛋白質組學、代謝體學和基因組學的多組體學平台的市場開拓預計將為市場帶來成長前景。
主要市場統計 | |
---|---|
基準年[2023] | 52118萬美元 |
預測年份 [2024] | 5.8666億美元 |
預測年份 [2030] | 1,237.48 百萬美元 |
複合年成長率(%) | 13.14% |
質譜技術的普及,取得產品組織中各種分子的空間分佈
消耗品包括樣品製備、成像和資料分析所需的試劑、探針、抗體和緩衝液等關鍵組件。研究人員對耗材的偏好因樣品類型、目標分子、靈敏度等級、通量需求和預算限制等因素而異。該儀器是在空間組學實驗中產生各種解析度的高品質資料的重要工具。關鍵設備包括顯微鏡、玻片掃描儀、質譜儀和次世代定序儀。質譜成像涉及直接分析來自組織切片的分子數量的空間分佈,通常放置在導電載玻片上以使樣品表面導電。軟體對於透過影像分割工具分析和解釋空間組學資料至關重要。使用者偏好取決於硬體相容性、易用性、與現有資料分析流程和 LIMS 系統的整合、可擴展性和自訂選項等因素。
最終用途學術研究機構和轉化研究機構如何使用空間組學技術研究細胞機制的案例
學術和轉化研究機構正在採用空間組學技術來增強其研究能力。空間組學工具使學術和轉化研究機構能夠加深對細胞機制、疾病進展和生物標記識別的理解,並為新型治療性介入的研究和開發做出貢獻。製藥和生物技術公司使用空間組學技術來確定目標的優先順序、識別生物標記並簡化藥物發現過程。
區域洞察
由於美國和加拿大等地區對研發的大量投資,以及生技公司、研究機構和學術機構的支持,全球太空組學市場正在新興市場顯著成長。在歐洲,瑞典和德國等國家透過「地平線 2020」等歐盟資助的計劃在太空組學技術投資方面處於主導。歐洲生物資訊實驗室 (EMBL) 和 Wellcome Sanger研究所等研究機構為此領域的發展做出了重大貢獻。在中東地區,人們越來越關注精準醫學和基因組研究,擴大了在臨床決策中使用空間 OMIC 技術的機會。此外,鑑於生物技術領域的成長以及中國和印度等主要經濟體政府對科學研究的資助增加,亞太地區的 OMICS 在這一領域具有巨大的成長潛力。透過生物技術部 (DBT) 的大力投資,Spatial OMIC 技術正在印度逐漸被採用,這可能為對此類創新應用感興趣的研究人員和行業參與企業之間的合作鋪平道路。
FPNV定位矩陣
FPNV定位矩陣對於評估Spatial OMICS市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對 Spatial OMICS 市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動和突破性產品開發的智力見解。
1. 空間組學市場的市場規模與預測是多少?
2.在空間組學市場預測期內,我們應該考慮投資哪些產品與應用?
3. 空間組學市場的技術趨勢和法規結構是什麼?
4.空間組學市場主要廠商的市場佔有率是多少?
5. 進入空間組學市場的適當形式和策略手段是什麼?
[188 Pages Report] The Spatial OMICS Market size was estimated at USD 521.18 million in 2023 and expected to reach USD 586.66 million in 2024, at a CAGR 13.14% to reach USD 1,237.48 million by 2030.
Spatial omics encompasses advanced techniques and technologies for analyzing the spatial organization of biological molecules within cells, tissues, and organisms. This sector serves various industries, including pharmaceuticals, biotechnology, academic research, and diagnostics. Factors such as the rising prevalence of complex diseases like cancer, along with the advancements in next-generation sequencing (NGS) and government funding for life science research initiatives, have increased the application areas of spatial omics. However, high costs associated with implementing advanced imaging tools, along with data standardization and interoperability concerns, may impede market growth. However, booming technologies such as artificial intelligence (AI) and machine learning (ML) hold the potential to revolutionize data analysis in spatial omics studies. Furthermore, the development of integrated multi-omics platforms that combine transcriptomics, proteomics, metabolomics, and genomics, leveraging cloud computing technology, is expected to provide growth prospects for the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 521.18 million |
Estimated Year [2024] | USD 586.66 million |
Forecast Year [2030] | USD 1,237.48 million |
CAGR (%) | 13.14% |
Product: Penetration of mass spectrometry for spatial distribution of different molecules from tissue
Consumables include vital components such as reagents, probes, antibodies, and buffers for sample preparation, imaging, and data analysis. Researchers' preferences for consumables depend on factors such as sample type, target molecule, sensitivity levels, throughput needs, and budget constraints. Instruments are essential tools that generate high-quality data at various resolutions in spatial OMICS experiments. Key instruments encompass microscopes, slide scanners, mass spectrometry instruments, and next-generation sequencing platforms. Mass spectrometry imaging analyzes the spatial distribution of the number of molecules directly from tissue sections, usually placed on conductive glass slides to create conductivity on the sample surface. Software is vital for analyzing and interpreting spatial OMICS data through image segmentation tools. User preferences are determined by factors such as hardware compatibility, ease of use, integration with existing data analysis pipelines or LIMS systems, scalability, and customization options.
End-use: Significant application of spatial OMICS technologies by Academic & translational research institutes for cellular mechanisms studies
Academic & translational research institutes adopt spatial OMICS technologies to advance their research capabilities. Spatial OMICS tools allow academic & translational research institutes to have a better understanding of cellular mechanisms, disease progression, biomarker identification, and contribute towards the development of novel therapeutic interventions. Pharmaceutical & biotechnology companies are utilizing the Spatial OMICS technologies for prioritize target validation, biomarker identification, and streamlining drug discovery processes.
Regional Insights
The global spatial OMICS market is experiencing significant growth across the Americas region owing to significant investment led in research and development across regions such as the United States & Canada, supported by the presence of biotechnology & research companies along with academic institutions. In Europe, countries like Sweden and Germany lead investments in spatial OMICS technologies through EU-funded projects like Horizon 2020. Research institutes such as The European Bioinformatics Institute(EMBL) and Wellcome Sanger Institute contribute significantly to advancing this field. Increasing focus on precision medicine and genomic research in the Middle East region opens up opportunities for adopting spatial OMIC technologies in clinical decision-making. Moreover, the Asia Pacific region holds the growth potential for the spatial OMICS, considering the growing biotechnology sectors and increased government funding for scientific research across major economies such as China & India. India is gradually adopting spatial OMIC technology through substantial investments by its Department of Biotechnology (DBT), potentially paving the way for partnerships between researchers and industry players interested in these innovative applications.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Spatial OMICS Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Spatial OMICS Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Spatial OMICS Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Akoya Biosciences, Inc., Bio-Techne Corporation, Biognosys AG, BioSpyder Technologies Inc., Brooks Automation, Inc., Bruker Corporation, Danaher Corporation, Dovetail Genomics, LLC by Cantata Bio, LLC, Hologic, Inc., IonPath, Inc., Lunaphore Technologies S.A., Molecular Machines & Industries GmbH, NanoString Technologies, Inc., PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve BioSciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics Inc, Standard BioTools Inc., Ultivue, Inc., Veranome Biosystems, LLC by Applied Materials, Inc., and Vizgen, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Spatial OMICS Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Spatial OMICS Market?
3. What are the technology trends and regulatory frameworks in the Spatial OMICS Market?
4. What is the market share of the leading vendors in the Spatial OMICS Market?
5. Which modes and strategic moves are suitable for entering the Spatial OMICS Market?